Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2022-04-01
Colección:Thrombosis Journal
Materias:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Acceso en línea:https://doi.org/10.1186/s12959-022-00380-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares